Venable advised CSG-BIO, LLC, an experienced operator in the biomaterial banking industry, in connection with the acquisition of AlphaCord in partnership with Corbel Capital Partners, a Los Angeles-based investment firm, and CCS Growth Partners, a healthcare-focused independent sponsor. Founded in 2002 and headquartered in Atlanta, Georgia, AlphaCord is one of the leading providers of biomaterial banking services, focusing on the collection, processing, and storage of cord blood, cord tissue, placental tissue, and semen. CSG-BIO’s, Corbel’s, and CCS’s operational and financial support will enable AlphaCord to further expand its marketing efforts, improve the services it provides to the marketplace, and increase its geographic reach.
The Venable team was led by Jennifer Cappelletty and Ronn Davids, with support from Jessie Hervitz, Ryan Andrews, Rebecca Lee and Chris Davidson.